The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma

J Allergy Clin Immunol. 2004 Sep;114(3):688-9. doi: 10.1016/j.jaci.2004.05.051.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Asthmatic Agents / therapeutic use*
  • Aspirin / adverse effects*
  • Asthma / drug therapy*
  • Asthma / genetics
  • Drug Hypersensitivity / etiology*
  • Female
  • Genetic Markers*
  • HLA-DP Antigens / genetics*
  • HLA-DP beta-Chains
  • Humans
  • Leukotriene Antagonists / therapeutic use*
  • Male
  • Middle Aged
  • Predictive Value of Tests

Substances

  • Anti-Asthmatic Agents
  • Genetic Markers
  • HLA-DP Antigens
  • HLA-DP beta-Chains
  • HLA-DPB1 antigen
  • Leukotriene Antagonists
  • Aspirin